Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

CDXS – Codexis, Inc.

Codexis, Inc.
CDXS
$2.47
Name : Codexis, Inc.
Sector : Healthcare
Industry: Biotechnology
Mark. Cap: $204,626,656.00
EPSttm : -0.89
finviz dynamic chart for CDXS
Codexis, Inc.
$2.47
3.52%
$0.09

Float Short %

7.06

Margin Of Safety %

Put/Call OI Ratio

0.13

EPS Next Q Diff

-0.02

EPS Last/This Y

0.31

EPS This/Next Y

0.09

Price

2.48

Target Price

7.33

Analyst Recom

1.57

Performance Q

-40.05

Relative Volume

0.72

Beta

2.57

Ticker: CDXS




23 items of 1

DateSymbolLastP/C OIP/C VolTotal OI
2025-04-14CDXS2.290.218.00696
2025-04-15CDXS2.250.280.00736
2025-04-16CDXS2.120.280.00736
2025-04-17CDXS2.120.27999.99764
2025-04-18CDXS2.110.27999.99764
2025-04-21CDXS2.140.180.00643
2025-04-22CDXS2.230.160.00744
2025-04-23CDXS2.270.160.00744
2025-04-24CDXS2.30.150.00767
2025-04-25CDXS2.260.146842878120410781
2025-04-28CDXS2.330.146842878120410781
2025-04-29CDXS2.340.150.00781
2025-04-30CDXS2.310.150.00781
2025-05-01CDXS2.330.150.00767
2025-05-02CDXS2.520.150.00769
2025-05-05CDXS2.50.150.00789
2025-05-06CDXS2.250.150.00789
2025-05-07CDXS2.280.150.00789
2025-05-08CDXS2.450.140.00790
2025-05-09CDXS2.460.140.00790
2025-05-12CDXS2.640.150.00785
2025-05-13CDXS2.560.150.00788
2025-05-14CDXS2.480.130.53847
DateSymbolLastP/C OIP/C VolTotal OI
23 items Current Page1 of 1




23 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2025-04-14CDXS2.30-23.4- -0.58
2025-04-15CDXS2.25-23.4- -0.58
2025-04-16CDXS2.12-23.4- -0.58
2025-04-17CDXS2.11-23.4- -0.58
2025-04-18CDXS2.11-23.4- -0.58
2025-04-21CDXS2.14-23.4- -0.58
2025-04-22CDXS2.23-23.4- -0.58
2025-04-23CDXS2.28-23.4- -0.58
2025-04-24CDXS2.29-23.4- -0.58
2025-04-25CDXS2.26-23.4- -0.58
2025-04-28CDXS2.33-23.4- -0.58
2025-04-29CDXS2.33-23.4- -0.58
2025-04-30CDXS2.30-23.4- -0.58
2025-05-01CDXS2.33-23.4- -0.58
2025-05-02CDXS2.52-23.4- -0.58
2025-05-05CDXS2.50-23.4- -0.58
2025-05-06CDXS2.25-23.4- -0.58
2025-05-07CDXS2.28-23.4- -0.58
2025-05-08CDXS2.45-23.4- -0.58
2025-05-09CDXS2.46-23.4- -0.58
2025-05-12CDXS2.64-23.4- -0.58
2025-05-13CDXS2.56-29.7- -0.58
2025-05-14CDXS2.48-29.7- -0.58
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
23 items Current Page1 of 1




23 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2025-04-14CDXS66.693.856.34
2025-04-15CDXS66.693.856.34
2025-04-16CDXS66.693.856.34
2025-04-17CDXS66.693.856.34
2025-04-18CDXS85.123.856.34
2025-04-21CDXS85.126.316.34
2025-04-22CDXS85.126.316.34
2025-04-23CDXS85.126.316.34
2025-04-24CDXS85.126.316.34
2025-04-25CDXS85.126.316.34
2025-04-28CDXS85.126.356.65
2025-04-29CDXS85.106.356.65
2025-04-30CDXS85.106.356.65
2025-05-01CDXS85.106.356.65
2025-05-02CDXS91.926.356.65
2025-05-05CDXS91.934.746.65
2025-05-06CDXS91.934.746.65
2025-05-07CDXS91.924.746.65
2025-05-08CDXS91.924.746.65
2025-05-09CDXS91.924.746.65
2025-05-12CDXS91.933.377.06
2025-05-13CDXS91.933.377.06
2025-05-14CDXS91.923.377.06
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
23 items Current Page1 of 1

Last Quarter Act. EPS

-0.13

Avg. EPS Est. Current Quarter

-0.2

Avg. EPS Est. Next Quarter

-0.15

Insider Transactions

91.92

Institutional Transactions

3.37

Beta

2.57

Average Sales Estimate Current Quarter

10

Average Sales Estimate Next Quarter

14

Fair Value

Quality Score

28

Growth Score

36

Sentiment Score

57

Actual DrawDown %

94.1

Max Drawdown 5-Year %

-96.4

Target Price

7.33

P/E

Forward P/E

PEG

P/S

3.45

P/B

3.02

P/Free Cash Flow

EPS

-0.9

Average EPS Est. Cur. Y​

-0.58

EPS Next Y. (Est.)

-0.49

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-109.99

Relative Volume

0.72

Return on Equity vs Sector %

-121.2

Return on Equity vs Industry %

-104.4

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Codexis, Inc.
Sector: Healthcare
Industry: Biotechnology
Employees: 188
Codexis, Inc. provides enzymatic solutions for therapeutics manufacturing, leveraging its proprietary CodeEvolver technology platform to discover, develop, and enhance novel enzymes in the United States, Canada, Latin America, Europe, the Middle East, Africa, Australia, New Zealand, Southeast Asia, and China. The company develops its proprietary ECO Synthesis manufacturing platform to enable the scaled manufacture of RNAi therapeutics through an enzymatic route. It has a license agreement with Aldevron LLC and Pfizer Inc. The company was incorporated in 2002 and is headquartered in Redwood City, California.
stock quote shares CDXS – Codexis, Inc. Stock Price stock today
news today CDXS – Codexis, Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch CDXS – Codexis, Inc. yahoo finance google finance
stock history CDXS – Codexis, Inc. invest stock market
stock prices CDXS premarket after hours
ticker CDXS fair value insiders trading